Inflammatory bowel disease and risk of coronary heart disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Trends in cardiovascular medicine

• Publication date

  2015-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.tcm.2015.03.010PMID 25912602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology, risk factors and management of cardiovascular diseases in IBD

  2015cited by this paper
• Cardiorheumatology: cardiac involvement in systemic rheumatic disease

  2015cited by this paper
• The role and utility of faecal markers in inflammatory bowel disease

  2015cited by this paper
• Prevention of cardiovascular disease.

  2015cited by this paper
• Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.

  2014cited by this paper
• Is atherosclerosis an autoimmune disease?

  2014cited by this paper
• Epidemiology of inflammatory bowel disease: focus on Asia.

  2014cited by this paper
• Carotid Intima-Media Thickness in Patients With Inflammatory Bowel Disease

  2014cited by this paper
• Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Synopsis of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline

  2014cited by this paper
• Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.

  2014cited by this paper
• Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease

  2014influential reference
• Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies.

  2014cited by this paper
• Diagnosis and classification of Crohn's disease.

  2014cited by this paper
• Long-term Risk of Acute Coronary Syndrome in Patients with Inflammatory Bowel Disease: A 13-year Nationwide Cohort Study in an Asian Population

  2014cited by this paper
• Diagnosis and classification of ulcerative colitis.

  2014cited by this paper
• Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease.

  2014cited by this paper
• Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.

  2014cited by this paper
• Conventional Risk Factors and Cardiovascular Outcomes of Patients with Inflammatory Bowel Disease with Confirmed Coronary Artery Disease

  2014cited by this paper
• The burden of inflammatory bowel disease in Europe.

  2013cited by this paper
• Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

  2013cited by this paper
• Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study

  2013cited by this paper
• Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

  2013cited by this paper
• Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study

  2012influential reference
• Risk of Subsequent Coronary Heart Disease in Patients Hospitalized for Immune-Mediated Diseases: A Nationwide Follow-Up Study from Sweden

  2012cited by this paper
• Crohn's disease

  2012cited by this paper
• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

  2012cited by this paper
• Arterial stiffness is increased in patients with inflammatory bowel disease

  2012cited by this paper
• Are patients with inflammatory bowel disease at increased risk of coronary artery disease?

  2012cited by this paper
• Ulcerative colitis.

  2011cited by this paper
• Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events

  2011cited by this paper
• Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease.

  2011cited by this paper
• Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients.

  2011influential reference
• No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease.

  2011cited by this paper
• Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management

  2010cited by this paper
• Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

  2010cited by this paper
• Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

  2010cited by this paper
• Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

  2010cited by this paper
• Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease

  2009cited by this paper
• Inflammatory bowel disease and coronary artery disease

  2009influential reference
• Hypocholesterolemia in clinically serious conditions--review.

  2008cited by this paper
• The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.

  2008cited by this paper
• What effects might anti-TNFα treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFα in cardiovascular pathophysiology

  2007cited by this paper
• Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000

  2007cited by this paper
• Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence

  2006cited by this paper
• The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study

  2006cited by this paper
• Platelets in inflammation and atherogenesis.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications

  2004cited by this paper
• Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.

  2004cited by this paper
• Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice.

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls

  2000cited by this paper
• ULCERATIVE colitis.

  1997cited by this paper

• Inflammatory bowel disease is associated with an increased risk of cardiovascular events in a sex and age-dependent manner: A historical cohort study

  2025cites this paper
• FOSB is a key factor in the genetic link between inflammatory bowel disease and acute myocardial infarction: multiple bioinformatics analyses and validation

  2025cites this paper
• Ulcerative colitis increases the risk of atrioventricular block: evidence from a Mendelian randomized analysis

  2025cites this paper
• Cardiovascular Risk in Patients with Inflammatory Bowel Diseases—The Role of Endothelial Dysfunction

  2024cites this paper
• Association between inflammatory bowel disease and atrial fibrillation: A systematic review and meta-analysis

  2024cites this paper
• Evaluation of Endothelial Dysfunction via Flow-Mediated Dilation in Patients with Inflammatory Bowel Disease Referred to Medical Centers in Kerman

  2024cites this paper
• Identification of key biomarkers for predicting CAD progression in inflammatory bowel disease via machine‐learning and bioinformatics strategies

  2024cites this paper
• Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study

  2024cites this paper
• Risk of atrial fibrillation development in adolescent patients with inflammatory bowel disease

  2024cites this paper
• Metabolic stress in patients with acute severe ulcerative colitis - a single-center cohort study

  2024cites this paper
• Insulin resistance as a cardiovascular risk factor in patients with ulcerative colitis

  2024cites this paper
• Assessing the causal relationship between metabolic biomarkers and coronary artery disease by Mendelian randomization studies

  2024cites this paper
• Cardiovascular Manifestations in Inflammatory Bowel Disease

  2023cites this paper
• Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies.

  2023cites this paper
• Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation

  2023cites this paper
• Inflammatory bowel disease and cardiovascular disease: A two-sample Mendelian randomization analysis

  2022cites this paper
• MicroRNAs in Inflammatory Bowel Disease and Its Complications

  2022cites this paper
• Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.

  2022cites this paper
• Evaluation of Tp-e interval and Tp-e/QTc ratio in patients with inflammatory bowel disease

  2022cites this paper
• Review article: guide to tofacitinib dosing in patients with ulcerative colitis

  2022cites this paper
• Vinculum of Cardiovascular Disease and Inflammatory Bowel Disease: A Narrative Review

  2022cites this paper
• Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies.

  2021cites this paper
• Evaluation of epicardial adipose tissue and carotid intima-media thickness as a marker of atherosclerosis in patients with inflammatory bowel disease.

  2021influential citation
• The risk of cardiovascular complications in inflammatory bowel disease

  2020cites this paper
• Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.

  2020cites this paper
• Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.

  2020cites this paper
• Plasma lipids in patients with inflammatory bowel disease

  2020cites this paper
• Cardiovascular Risk in Individuals with Inflammatory Bowel Disease

  2020cites this paper
• Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation.

  2020cites this paper
• Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk.

  2020cites this paper
• Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease.

  2020cites this paper
• Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease

  2020cites this paper
• Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management

  2020cites this paper
• Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome?

  2020cites this paper
• Inflammation in Cardiovascular Disease: From Basic Concepts to Clinical Application

  2020cites this paper
• Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.

  2020cites this paper
• Cardiovascular Risk in Individuals with In fl ammatory Bowel Disease

  2020cites this paper
• Measurement of Microvascular Function in Pediatric Inflammatory Bowel Disease

  2019cites this paper
• Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies

  2019cites this paper
• The role of interleukin-32 in the increased cardiovascular risk associated with chronic inflammatory diseases

  2018cites this paper
• USE OF CARDIAC BIOMARKERS FOR PREDICTION OF CORONARY HEART DISEASE IN FAMILY MEMBERS OF DIABETICS IN JOS NIGERIA

  2018influential citation
• Endocytosis of lipoproteins.

  2018cites this paper
• Increased arterial stiffness – similar findings in patients with inflammatory bowel disease without prior hypertension or diabetes and in patients with well-controlled hypertension

  2018cites this paper
• Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.

  2018cites this paper
• Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta‐Analysis of Cohort Studies

  2017influential citation
• Bowel Disease and Risk of Ischemic Heart Disease : An Updated Meta-Analysis of Cohort Studies

  2017influential citation
• Oxidation During Digestion of Meat: Interactions with the Diet and Helicobacter pylori Gastritis, and Implications on Human Health.

  2017cites this paper
• Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.

  2017cites this paper
• Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment

  2016cites this paper
• Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis

  2016cites this paper
• Heart Rate Recovery Is Impaired in Patients with Inflammatory Bowel Diseases

  2016cites this paper
• Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease

  2016cites this paper
• Risk of cardiovascular disease in inflammatory bowel disease

  2016cites this paper
• Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?

  2016influential citation
• Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database

  2016cites this paper
• Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox.

  2015cites this paper
• Long-term risk of cardiovascular and cerebrovascular disease after removal of the colonic microbiota by colectomy: a cohort study based on the Danish National Patient Register from 1996 to 2014

  2015cites this paper